Amazon's GLP‑1 program
- Amazon launched a nationwide GLP‑1 weight‑loss management program through One Medical and Amazon Pharmacy. ( ) - The program pairs primary care with personalized treatment plans and transparent medication pricing. ( ) - Coverage says the rollout aims to widen access and move weight‑loss care toward longer‑term management. (courierpostonline.com)
Amazon has started selling a nationwide weight-management program that puts GLP-1 obesity drugs inside its One Medical primary-care service and Amazon Pharmacy. (aboutamazon.com) (usatoday.com) The company announced the program on April 21, 2026, and said it combines clinician visits, ongoing monitoring, nutrition and exercise support, and prescription fulfillment in one system. (usatoday.com) (healthcaredive.com) Amazon said insured patients can get GLP-1 medicines starting at $25 a month, while cash-pay options start at $149 a month through Amazon Pharmacy. Coverage of the launch identified Novo Nordisk’s Wegovy and Eli Lilly’s oral Foundayo among the drugs offered. (cnbc.com) (strategichealthcare.net) GLP-1 drugs were first used for type 2 diabetes and now also for obesity; they work in part by mimicking gut hormones that reduce appetite and slow digestion. One Medical has been publishing patient education around the drugs as demand has spread beyond specialist obesity clinics. (onemedical.com) (forbes.com) Amazon is pitching the new service as chronic-care management, not a one-time prescription. The company said patients will get continued medical supervision and follow-up through One Medical clinicians rather than a standalone telehealth script. (aboutamazon.com) (kiro7.com) The launch extends Amazon’s healthcare buildout after its $3.9 billion acquisition of One Medical closed in February 2023. Since then, Amazon has used One Medical memberships, virtual care, and Amazon Pharmacy to tie doctor visits and prescriptions more tightly together. (aboutamazon.com 1) (aboutamazon.com 2) Amazon has already been leaning into the economics of these drugs. In March, Amazon Pharmacy said customers had saved more than $200 million through automatic manufacturer coupons, with GLP-1 medicines representing the largest category of savings. (press.aboutamazon.com) The immediate test is whether Amazon can turn a drug boom into a longer-running primary-care business. The company is betting that easier prescribing, clearer prices, and refill support will keep patients inside its health system after the first prescription. (healthcaredive.com) (aboutamazon.com)
